Refine Results
- Content Type
-
Content Type
- Analysis Platform
-
Product
- Language
-
Language
Recently updated Cancer Immunotherapy Handbook featuring the latest high impact xCELLigence publications and newly released supporting information.
- Publication Part Number: 5994-1303EN
- Created: 08 July 2025
- 6 MB
Describes use of a tethering approach to immobilize liquid tumor cell lines on to the surface of gold biosensors embedded in an Agilent E-Plate.
- Publication Part Number: 5994-1066EN
- Created: 27 June 2025
- 687 KB
This document is an information guide and checklist prepared for you that outlines the supplies, space, and utility requirements for the system set up in your lab.
- Publication Part Number: 300600890
- Created: 01 Apr 2025
- 537 KB
AACR 2025 poster: Chronic anti-CD3/CD28 stimulation during cell expansion generates exhausted T cells with a distinct metabolic and cytotoxic phenotype
- Publication Part Number: AACR #4856
- Created: 25 Apr 2025
- 475 KB
This editorial showcases Agilent solutions for metabolic modulation enhancing CAR T-cell activation, persistence, and serial killing for improved cancer immunotherapy
- Publication Part Number: 5994-7739EN
- Created: 04 Nov 2024
- 830 KB
Poster from SOT 2024. Drug safety testing can be optimized using HUREL micro livers on two Agilent cell analysis platforms: Seahorse XF Pro and xCELLigence RTCA Analyzer.
- Created: 08 May 2024
- 895 KB
This editorial will discuss the potency assays available for cellular immunotherapies, the regulatory criteria they must meet, and the challenges faced in measuring immune cell cytotoxicity.
- Publication Part Number: 5994-7162EN
- Created: 15 Feb 2024
- 1 MB
This quick reference guide describes the setup of experiments on the xCELLigence RTCA SP system (00380601030) using RTCA Software PRO (v2.0 and newer).
- Publication Part Number: 5994-4999
- Created: 08 Feb 2024
- 366 KB